ArticleActa anaesthesiologica Scandinavica2026
Anaesthetic Type and Survival in Metastatic Colorectal Cancer: A Nationwide Registry Study.
Article in Acta anaesthesiologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe impact of anaesthetic choice on survival following metastatic cancer surgery is uncertain. Inhalational anaesthetics, such as sevoflurane, may promote inflammation and tumour progression, while the intravenous agent propofol has been suggested to be anti-inflammatory. This study aimed to evaluate the association between anaesthetic maintenance with inhalational anaesthesia versus propofol-based total intravenous anaesthesia and overall survival in patients undergoing surgery for metastatic colorectal cancer.
methodsAdult patients (≥ 18 years) with metastatic colorectal cancer who underwent elective or emergency surgery under general anaesthesia from 2014 to 2019 were identified in the Swedish Colorectal Cancer Registry and matched with the Swedish Perioperative Registry. Cox regression, propensity score-matching (2:1, inhalational anaesthesia: propofol), and Kaplan-Meier analysis were used to assess survival.
resultsOf the 1233 included patients, 1011 received maintenance anaesthesia with an inhalational agent, and 222 received propofol. Cox regression analysis identified significant associations between overall survival and advanced age, higher ASA class, emergency surgery, open surgical approach and right-sided tumour location. Comparison of anaesthetics for the full unmatched cohort observed a statistically significant increased risk of death with propofol (hazard ratio [HR] 1.26, 95% CI 1.02-1.55, p = 0.032). Propensity score-matching yielded 639 matched patients (inhalants 426; propofol 213) with Kaplan-Meier analysis showing comparable survival between groups, with 1- and 3-year survival rates of 75% and 43% for inhalants versus 73% and 41% for propofol. In the matched cohort, the HR for propofol versus inhalants in a Cox regression analysis was 1.13 (95% CI 0.89-1.42, p = 0.32).
conclusionAn apparent association between propofol maintenance and increased mortality observed in the full unmatched cohort was not confirmed in the propensity score-matched cohort. Poorer survival was independently associated with advanced age, higher ASA class, right-sided tumours and open surgical approach. EDITORIAL COMMENT: It is still not known if clinical anaesthetic exposure can affect cancer outcomes. This retrospective analysis of metastatic colorectal cancer surgical cases looked for associations for anaesthesia management factors, or maintenance of anaesthesia with propofol or inhalational agents, and long-term survival. When the anaesthesia exposure cases were matched for other known mortality risk factors, there was no anaesthesia-related mortality risk difference over time between groups in this cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.